Boston Heart Dx Completes New York's Clinical Lab Permitting Process | GenomeWeb

NEW YORK (GenomeWeb News) – Boston Heart Diagnostics today announced it successfully completed the New York State Department of Health clinical laboratory permitting process.

As a result, the company can administer its tests to patients in all 50 states in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.